Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Case Study · May 23, 2023

Dramatic Response to Pyrotinib and T-DM1 in a Patient With HER2− MBC With Two Activating HER2 Mutations

The Oncologist


Additional Info

The Oncologist
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations
Oncologist 2023 Apr 29;[EPub Ahead of Print], H Tian, M Qu, G Zhang, L Yuan, Q Shi, Y Wang, Y Yang, Y Zhang, X Qi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading